Using ctDNA to Determine Therapies for Lung Cancer

Clinical trial NCT04966663 · RECRUITING

Trial details

NCT number: NCT04966663
Sponsor: University Health Network, Toronto
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer Complete Surgical Resection Circulating Tumor DNA

Start date: 2022-03-28
Primary completion: 2026-08-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.